Agribusiness

 

Consumer Goods

 

Heavy Industry

 

Hi-Tech & Media

 

Life Sciences

 

Services

 

Countries

Talk to Sam

+1 71 86 18 43 02

Add to circles RSS feed

Search inside this page

Top countries

Publication dates

All regions

data types

Free Market Research Guides to Download

Free Market Research Guides to Download

Conduct your own Porter Five Forces Analysis on the Therapy Industry

Assess your competitors in the Therapy Industry

Conduct your own Pestel Analysis

Therapy Market Statistics, June 2013

» Read Business News

1-30 of about 1 700 news
Radiation Therapy Production Capacity in The United States: Sales of 5 C-RAD Sentinel and Catalyst systems sold radiation therapy clinics in the US

Radiation Therapy Production Capacity In The United States: Sales Of 5 C-rad Sentinel And Catalyst Systems Sold Radiation Therapy Clinics In The Us

  • Company news
  • 16 hours ago
  • by OMX

Press release June 18, 2013 C-RAD AB with its 3 fully owned subsidiaries , 3 international sales companies are all active in the field of radiation therapy. After the decline of the US Industry in 2012 a recovery can be seen. C-RAD has during last months sold 5 Sentinel , Catalyst systems to clinics in the US. The Catalyst system is based on a new generation hardware , software p...

  • Industries : Therapy
  • Countries : United States
Immunotherapy Innovation Trends in France and The United States: U.S. Patent granted to Vaxon Biotech on 2013-06-18 for

Immunotherapy Innovation Trends In France And The United States: U.s. Patent Granted To Vaxon Biotech On 2013-06-18 For "identification, Optimization And Use Of Cryptic Hla-b7 Epitopes For Immunotherapy" (french...

  • Company news
  • 1 day ago
  • by HT Media

U.S. Patent granted to Vaxon Biotech on 2013-06-18 for "Identification, optimization , use of cryptic HLA-B7 epitopes for immunotherapy" (French Inventors) ALEXANDRIA, Va. , June 18 -- United States Patent no. 8,465,747, issued on June 18 , was assigned to Vaxon Biotech (Evry Cedex, France ). "Identification, optimization , use of cryptic HLA-B7 epitopes for immunotherapy" was inv...

  • Industries : Therapy
  • Countries : France, United States
Chemotherapy Innovation in The United States: U.S. Patent granted to Duke University on 2013-06-18 for

Chemotherapy Innovation In The United States: U.s. Patent Granted To Duke University On 2013-06-18 For "use Of An Agent That Restores Tissue Perfusion And Oxygenation" (belgian, American Inventors)

  • Industry news
  • 1 day ago
  • by HT Media

ALEXANDRIA, Va. , 2013-06-18 -- United States Patent no. 8,466,110, issued on June 18 , was assigned to Duke University ( Durham, N.C. ). "Use of an agent that restores tissue perfusion , oxygenation" was invented by Mark W. Dewhirst ( Durham, N.C. ), Jonathan S. Stamler ( Chapel Hill, N.C. ), Timothy J. McMahon ( Durham, N.C. ) , Pierre Sonveaux (Ottignies-Louvain-la-Neuve, Be...

  • Industries : Therapy
  • Countries : United States
Radiation Therapy Technology Trends in The United States: Breya Assigned Patent

Radiation Therapy Technology Trends In The United States: Breya Assigned Patent

  • Industry news
  • 2 days ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-06-17 -- Breya, Miami Beach, Fla. , has been assigned a patent (8,459,714) developed by Mark Elliot Pomper , Miami Beach, Fla. , , Aleksandar Jocic , Wilton Manors, Fla. , for a mobile radiation therapy. The abstract of the patent published by the U.S. Patent , Trademark Office states: "The invention provides techniques for diagnos...

  • Industries : Therapy
  • Countries : United States
Therapy Innovation in The United States: Supreme Court Asked For Further Clarity On Patent-Eligibility Of Diagnostic Claims

Therapy Innovation In The United States: Supreme Court Asked For Further Clarity On Patent-eligibility Of Diagnostic Claims

  • Industry news
  • 2 days ago
  • by Mondaq

Supreme Court Asked For Further Clarity On Patent-Eligibility Of Diagnostic Claims - Foley & Lardner ( United States ) 17 June 2013 By Ms Antoinette Konski Did the Federal Circuit incorrectly interpret , apply the holding of the U.S. Supreme Court's decision regarding patent-eligibility of medical methods as set forth in Mayo Collaborative Services v. Prometheus Laboratories...

  • Industries : Therapy
  • Countries : United States
Chemotherapy Trends in The United States: Zoltan Laboratories Assigned Patent

Chemotherapy Trends In The United States: Zoltan Laboratories Assigned Patent

  • Industry news
  • 4 days ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-06-15 -- Zoltan Laboratories , Austin, Minn. , has been assigned a patent (8,460,654) developed by Zoltan Kiss , Austin, Minn. , for a "use of alkaline phosphatase to maintain healthy tissue mass in mammals." The abstract of the patent published by the U.S. Patent , Trademark Office states: "Embodiments of the present invention relate...

  • Industries : Therapy
  • Countries : United States
Therapeutics Innovation Trends in The United States: Trius Therapeutics Assigned Patent

Therapeutics Innovation Trends In The United States: Trius Therapeutics Assigned Patent

  • Company news
  • 5 days ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-06-14 -- Trius Therapeutics , San Diego , has been assigned a patent (8,461,188) developed by 4 Company-inventors for a "therapeutic combination of daptomycin , protein synthesis inhibitor antibiotic, , methods of use." The Company-inventors are Kenneth F. Bartizal , La Jolla, Calif. , Jeffrey B. Locke , ...

  • Industries : Therapy
  • Countries : United States
Therapy Innovation Trends in New Zealand: World Intellectual Property Organization PUBLISHES PATENT OF AUCKLAND UNISERVICES FOR

Therapy Innovation Trends In New Zealand: World Intellectual Property Organization Publishes Patent Of Auckland Uniservices For "precoating Methods And Compositions" (new Zealander Inventor)

  • Company news
  • 5 days ago
  • by HT Media

GENEVA , 2013-06-14 -- Publication No. WO/2013/085400 was published on June 13 . Title of the invention: "PRECOATING METHODS , COMPOSITIONS." Applicants: AUCKLAND UNISERVICES LIMITED (NZ). Inventors: Kaluachchi Gamage Karnika De Silva (NZ). as reported by the abstract* posted by the World Intellectual Property Organization : "Methods , compositions for precoating a substrate. The...

  • Industries : Therapy
  • Countries : New Zealand
Radiation Therapy Innovation in The United States: Researchers from Department of Radiation Oncology Describe Findings in Radiation Therapy

Radiation Therapy Innovation In The United States: Researchers From Department Of Radiation Oncology Describe Findings In Radiation Therapy

  • Industry news
  • 5 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Robotics & Machine Learning -- Researchers detail new data in Drugs , Therapies. as reported by news reporting from Stanford, California , by VerticalNews journalists, research stated, "Although modern technology has allowed for target dose escalation by minimizing normal tissue dose, the dose delivered to a tumor , surrounding tissues still depends...

  • Industries : Therapy
  • Countries : United States
Therapy Technology Trends in The United States: Dignity Sciences declares Notification of Patent Allowance for U.S. Application 13/318,290, Protecting its Lead Candidate and Next Generation Compounds

Therapy Technology Trends In The United States: Dignity Sciences Declares Notification Of Patent Allowance For U.s. Application 13/318,290, Protecting Its Lead Candidate And Next Generation Compounds

  • Industry news
  • 5 days ago
  • by PR Web

Dublin, Ireland (PRWEB) 2013-06-13 Dignity Sciences Ltd , a privately held biopharmaceutical Industry player, announced today that the United States Patent , Trademark Office ( USPTO ) has issued a Notice of Allowance for U.S. patent application serial number 13/318,290, entitled "Use of PUFAs for Treating Skin Inflammation." The application has allowed claims that provide Dignity Scie...

  • Industries : Therapy
  • Countries : United States
Radiation Therapy Strategic Alliances in The United States: MedSolutions Enters Into an Oncology Management Alliance with Oncology Analytics

Radiation Therapy Strategic Alliances In The United States: Medsolutions Enters Into An Oncology Management Alliance With Oncology Analytics

  • Company news
  • 6 days ago
  • by ProQuest Information & Learning

MedSolutions , a provider of medical cost management services, launched a new alliance with Oncology Analytics, incorporated , an oncology benefits management , clinical decision support Industry player. as reported by a release, the combination of MedSolutions' existing Radiation Therapy Management Program , Oncology Analytics' Medical Oncology Management Program creates an outpatient oncology manage...

  • Industries : Therapy
  • Countries : United States
Therapeutics Technology Trends in North America: Edge Therapeutics Reports FDA Accepts IND Application for EG-1962

Therapeutics Technology Trends In North America: Edge Therapeutics Reports Fda Accepts Ind Application For Eg-1962

  • Industry news
  • 6 days ago
  • by ProQuest Information & Learning

Edge Therapeutics, incorporated , a clinical-stage biopharmaceutical Industry player, announced that the U.S. Food , Drug Administration has accepted the Industry player's Investigational New Drug application for EG- 1962, a novel bio-absorbable nimodipine microparticle formulation. as reported by a release, Edge is developing EG-1962 for the prevention of delayed cerebral ischemia, a life-threatening complicati...

  • Industries : Therapy
  • Countries : Canada, North America
Therapy Innovation Trends in The United States: Patent Issued for Aminopyrimidines Useful as Kinase Inhibitors

Therapy Innovation Trends In The United States: Patent Issued For Aminopyrimidines Useful As Kinase Inhibitors

  • Company news
  • 6 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Cancer Weekly -- From Alexandria, Virginia , NewsRx journalists report that a patent by the inventors Studley , John (Oxford, GB); Young, Stephen (Oxford, GB), filed on October 13, 2009 , was published online on 2013-06-04 (see also Vertex Pharmaceuticals Incorporated ). The patent's assignee for patent number 8455507 is Vertex Pharmaceu...

  • Industries : Therapy
  • Countries : United States
Therapeutics Market Shares in North America: CytomX Therapeutics Named a 2013 Red Herring Top 100 North America Tech Startup

Therapeutics Market Shares In North America: Cytomx Therapeutics Named A 2013 Red Herring Top 100 North America Tech Startup

  • Company news
  • 6 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Biotech Week -- CytomX Therapeutics, incorporated , a biotechnology Industry player developing a new generation of targeted antibody therapeutics, announced that it has been selected as a 2013 Red Herring Top 100 North America Tech Startup. Red Herring Top 100 awards recognize the leading private companies from the Americas , celebrating these startups' innovations ...

  • Industries : Therapy
  • Countries : North America
Therapy Innovation Trends in The United States: Insights from the GRACE study

Therapy Innovation Trends In The United States: Insights From The Grace Study

  • Company news
  • 6 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at AIDS Weekly -- Enrollment of women in clinical trials of new anti-HIV drugs is extremely low, representing only about 15 % of all treatment-experienced patients. For women of color it is even lower. Why women, , especially women of color, are so poorly represented in HIV drug trials is the focus of an important article in AIDS Patient Care , STDs,...

  • Industries : Therapy
  • Countries : United States
Therapy Technology Trends in Japan: Researchers from Kinki University Report Recent Findings in Spiritual Therapies

Therapy Technology Trends In Japan: Researchers From Kinki University Report Recent Findings In Spiritual Therapies

  • Industry news
  • 6 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on Spiritual Therapies are discussed in a new report. as reported by news reporting originating in Osaka, Japan , by NewsRx journalists, research stated, "The purpose of this study was to determine whether therapeutic touch in preterm infants can ameliorate their sensory punctate stimulus response in terms of ...

  • Industries : Therapy
  • Countries : Japan
Therapeutics Technology Trends in The United States and Taiwan: Findings in Therapeutics Reported from National Cheng Kung University

Therapeutics Technology Trends In The United States And Taiwan: Findings In Therapeutics Reported From National Cheng Kung University

  • Industry news
  • 6 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on Therapeutics are discussed in a new report. as reported by news reporting originating from Tainan , Taiwan , by NewsRx correspondents, research stated, "To examine the institutional contexts that contribute to the low priority given to the development of self-care independence in a rehabilitation ward. Res...

  • Industries : Therapy
  • Countries : United States, Taiwan
Cancer Therapeutics Corporate Deals Activity in The United States: Vical to Present at Wells Fargo Securities Healthcare Conference

Cancer Therapeutics Corporate Deals Activity In The United States: Vical To Present At Wells Fargo Securities Healthcare Conference

  • Company news
  • 6 days ago
  • by GlobeNewswire

SAN DIEGO , 2013-06-12 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the Industry player will provide an overview of its technologies, development programs, , outlook on Wednesday, June 19 , at 3:00 p.m. ET at the Wells Fargo Securities Healthcare Conference ( Boston , June 19 ? 20). About Vical Vical researches , develops biopharmaceutical pr...

  • Industries : Therapy
  • Countries : United States
Physiotherapy Innovation Trends in The United Kingdom: We won't be fit enough to work to 67, Britons fear

Physiotherapy Innovation Trends In The United Kingdom: We Won't Be Fit Enough To Work To 67, Britons Fear

  • Company news
  • Jun 12, 2013
  • by Telegraph Group

2 thirds of British workers fear they will be physically unable to work into their late 60s, as reported by a survey which found that 6 in 10 are not doing enough exercise to stay fit. The retirement age is due to rise to 66 for both sexes by 2020 , to 67 8 years later, but workers claim that by that age they will no longer be up to the job. Sixty per cent of those surveyed were ...

  • Industries : Therapy
  • Countries : United Kingdom
Radiotherapy Key Players: Emerging Markets To Thank For Elekta's Growth In 2012/13

Radiotherapy Key Players: Emerging Markets To Thank For Elekta's Growth In 2012/13

  • Industry news
  • Jun 11, 2013
  • by Business Monitor International

Elekta has revealed its business performance for the 2012/13 fiscal year, ended 30th April 2013 . Highlights of the performance included: o Order bookings increased by 14 per cent to SEK 12,117 million , from SEK 10,815 million in the year ended 30th April 2012 . o Net sales increased by 16 % to SEK 10,339 million , compared with SEK 9,048 in the prior year. o Operati...

  • Industries : Therapy
Radiation Therapy Innovation Trends in The United States: Varian Medical Systems Assigned Patent

Radiation Therapy Innovation Trends In The United States: Varian Medical Systems Assigned Patent

  • Company news
  • Jun 11, 2013
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-06-11 -- Varian Medical Systems , Palo Alto, Calif. , has been assigned a patent (8,453,281) developed by Steven C. Dimmer , Bellevue, Wash. , Matthew A. Herron , Palo Alto, Calif. , , Edward J. Vertatschitsch , Bellevue, Wash. , for "patient support systems for use with radiation therapy systems , other applications." The abstr...

  • Industries : Therapy
  • Countries : United States
Therapy Trends in The United States: U.S. Patent granted to Zoltan Laboratories on 2013-06-11 for

Therapy Trends In The United States: U.s. Patent Granted To Zoltan Laboratories On 2013-06-11 For "use Of Alkaline Phosphatase To Maintain Healthy Tissue Mass In Mammals" (minnesota Inventor)

  • Industry news
  • Jun 11, 2013
  • by HT Media

ALEXANDRIA, Va. , 2013-06-11 -- United States Patent no. 8,460,654, issued on June 11 , was assigned to Zoltan Laboratories LLC ( Austin, Minn. ). "Use of alkaline phosphatase to maintain healthy tissue mass in mammals" was invented by Zoltan Kiss ( Austin, Minn. ). as reported by the abstract* released by the U.S. Patent & Trademark Office : "Embodiments of the present invention relat...

  • Industries : Therapy
  • Countries : United States
Therapy Innovation Trends in The United States: U.S. Patent granted to Hill-Rom Services on 2013-06-11 for

Therapy Innovation Trends In The United States: U.s. Patent Granted To Hill-rom Services On 2013-06-11 For "high Frequency Chest Wall Oscillation System" (indiana, Ohio, Wisconsin, South Carolina,...

  • Company news
  • Jun 11, 2013
  • by HT Media

U.S. Patent granted to Hill-Rom Services on 2013-06-11 for "High frequency chest wall oscillation system" ( Indiana , Ohio , Wisconsin , South Carolina , Minnesota Inventors) ALEXANDRIA, Va. , June 11 -- United States Patent no. 8,460,223, issued on June 11 , was assigned to Hill-Rom Services Pte. Ltd. ( Singapore ). "High frequency chest wall oscillation system" was invented by Ke...

  • Industries : Therapy
  • Countries : United States
Radiation Therapy Innovation Trends in The United States: U.S. Patent granted to Breya on 2013-06-11 for

Radiation Therapy Innovation Trends In The United States: U.s. Patent Granted To Breya On 2013-06-11 For "mobile Radiation Therapy" (florida Inventors)

  • Company news
  • Jun 11, 2013
  • by HT Media

ALEXANDRIA, Va. , 2013-06-11 -- United States Patent no. 8,459,714, issued on June 11 , was assigned to Breya LLC ( Miami Beach, Fla. ). "Mobile radiation therapy" was invented by Mark Elliot Pomper ( Miami Beach, Fla. ) , Aleksandar Jocic ( Wilton Manors, Fla. ). as reported by the abstract* released by the U.S. Patent & Trademark Office : "The invention provides techniques for di...

  • Industries : Therapy
  • Countries : United States
Therapeutics Production Capacity in North America: FDA Accepts IND Application For Edge Therapeutics? EG-1962 (nimodipine microparticles)

Therapeutics Production Capacity In North America: Fda Accepts Ind Application For Edge Therapeutics? Eg-1962 (nimodipine Microparticles)

  • Company news
  • Jun 10, 2013
  • by Business Wire

Single Dose EG-1962 To Be Compared To Current Standard Of Care NEW PROVIDENCE, N.J. --(BUSINESS WIRE)-- Edge Therapeutics, incorporated , a clinical-stage biopharmaceutical Industry player focused on developing , commercializing life-saving hospital products for acute, fatal or debilitating conditions, announced today that the U.S. Food , Drug Administra...

  • Industries : Therapy
  • Countries : Canada, North America
Therapeutics Innovation Trends in Israel: IATI-BioMed

Therapeutics Innovation Trends In Israel: Iati-biomed

  • Company news
  • Jun 10, 2013
  • by GlobeNewswire

HAIFA, Israel , 2013-06-10 (GLOBE NEWSWIRE) -- Pluristem Therapeutics incorporated (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that Pluristem's CEO , its Project Innovation Research Manager will be delivering 2 different presentations during Israel's largest biotechnology conference, the 12 th Annual IATI-BioMed Conference June ...

  • Industries : Therapy
  • Countries : Israel
Therapy Innovation Trends in The United States: MacroGenics presents Phase I data at ASCO showing signs of clinical benefit for Margetuximab in HER2 expressing tumours.

Therapy Innovation Trends In The United States: Macrogenics Presents Phase I Data At Asco Showing Signs Of Clinical Benefit For Margetuximab In Her2 Expressing Tumours.

  • Company news
  • Jun 10, 2013
  • by Elsevier CBNB

MacroGenics incorporated announced that results of the 1st-in-human study of margetuximab were reported during an oral abstract session at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO). Howard A Burris, MD, FACP, 1st author , Chief Medical Officer of ...

  • Industries : Therapy
  • Countries : United States
Therapy Innovation Trends in The United States and Brazil: BAKER FUND AWARDS US Dollars 3 TO THREE OUTSTANDING RESEARCH PROJECTS FOR THE 2013 SPRING CYCLE

Therapy Innovation Trends In The United States And Brazil: Baker Fund Awards Us Dollars 3 To Three Outstanding Research Projects For The 2013 Spring Cycle

  • Company news
  • Jun 10, 2013
  • by HT Media

ATHENS, Ohio , 2013-06-10 -- Ohio University issued the following news release: The Baker Fund awards for the 2013 spring cycle have been announced , US Dollars 32083 3fund three projects that will assist OHIO faculty in completing active research projects. Awardees are Associate Professor of Music Therapy Kamile Geist in the College of Fine Arts ; Heritage College of Osteopathic Medi...

  • Industries : Therapy
  • Countries : United States, Brazil
Therapeutics Technology Trends: Insys Therapeutics reports 1Q 2013 results.

Therapeutics Technology Trends: Insys Therapeutics Reports 1q 2013 Results.

  • Industry news
  • Jun 7, 2013
  • by Elsevier CBNB

Insys Therapeutics incorporated announced its financial results for 1Q ended Mar 2013 . Total 1Q 2013 revenue increased to US Dollars 11.1 M ( US Dollars 2 M in 1Q 2012). Sales of Subsys added US Dollars 9.7 M in net revenue during 1Q 2013. The 1Q 2013 net income of US Dollars 100000 , diluted profits/share of US Dollars 0.01 (net loss of US Dollars 6.7 M , dilut...

  • Industries : Therapy
Therapy Innovation in The United States and Japan: Vycor's NovaVision unit awarded its 30th patent.

Therapy Innovation In The United States And Japan: Vycor's Novavision Unit Awarded Its 30th Patent.

  • Industry news
  • Jun 7, 2013
  • by Elsevier CBNB

Vycor Medical incorporated (Vycor) has been granted Japanese patent no JP5068770 for its NovaVision technology. The patent covers methods for performing vision therapy by stimulating areas of the patient's field of vision that are technically 'blind,' but may still respond positively to repeated stimulus to eventually improve or recover vision in the blind field. The claims complement other issued pa...

  • Industries : Therapy
  • Countries : World, United States, Japan

Reportlinker.com © Copyright 2013. All rights reserved.

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.